A drug used to combat skin cancer could also benefit patients suffering from Hairy Cell Leukemia (HCL) according to the latest study published in the New England Journal of Medicine (NEJM). Vemurafenib is a drug belongs to BRAF inhibitor group, approved for the treatment of advanced state melanomas and leukemia (blood cancer). It is possible … Continue reading A Drug For Skin Cancer Could Benefit Patients With Leukemia, New Research Says
Gazyva (obiutumab) has been approved by U.S Food and Drug Administration (FDA) to treat patients suffering from chronic lymphocytic leukemia (CLL) in combination with chlorambucil. It has been estimated by National Cancer Institute that nearly 15,680 people will be diagnosed and 4,580 will die due to CLL in America in 2013.
An international research effort in which the University of Essen would have been a participant has produced results which lay the basis for the completely new method of the treating of leukemia and lymphoma.
The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to deal with adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and marrow diseases.
The treating patients with chronic chronic myelocytic leukemia (CML) have to be ranked as one of the great medical success stories of history many years.
Synribo (omacetaxine mepesuccinate) has been approved by U.S. Food and Drug Administration for the treatment of chronic myelogenous leukemia (CML). It is estimated that 5,430 people will be diagnosed with CML in 2012, according to the National Institutes of Health.
A new orphan drug Bosulif (bosutinib) has been approved by U.S Drug and Food Administration for the treatment of chronic myelogenous leukemia (CML). It is a bone marrow disease in which older adults are mostly affected.
A new drug Marqibo (vincristine sulfate liposome injection) has been approved by U.S Food and Drug Administration to treat adults suffering from a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL).
Following drugs were approved by US Food and Drug Administration (FDA) in 2017 to treat numerous hematological disorders such as hemophilia, leukemia, sickle cell disease and etc. No. Brand Name Generic Name Therapeutic Uses Manufactured By Approval Date 01 Aliqopa Copanlisib Follicular Lymphoma Bayer September 2017 02 Besponsa Inotuzumab Ozogamicin Adults With Relapsed Or Refractory B-Cell Precursor Acute … Continue reading FDA Approved Drugs to Treat Hematological Disorders in 2017
Computed tomography (CT) and Positron Emission Tomography (PET) are frequently used to investigate numerous human diseases such as disorder of bones, central nervous system. cardiac system, cancer and etc. There are some comprehensible differences between CT scan and PET as discussed in the following table. Parameters CT Scan PET Scan Acronym Abbreviated as computed tomography Abbreviated … Continue reading Difference Between CT Scan And PET Scan